GFS Advisors, LLC

Position in MRNA — Moderna, Inc.

CIK 1427263 HOUSTON, TX

Position in MRNA

as of Jun 30, 2026 · filed Aug 4, 2026 Compact

Position Value

$11,345

-$5,068,655 QoQ

Shares Held

75,981

-24.0% QoQ

Ownership

0.019%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#616

of 772 holders

Holding Since

Mar 2026

2 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

GFS Advisors, LLC holds $62,285 across 5 Biotechnology names. MRNA ranks #2 (18.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RXRX	Recursion Pharmaceuticals, Inc.	10,000	$36,700
2	MRNA	Moderna, Inc. This page	75,981	$11,345
3	REGN	Regeneron Pharmaceuticals, Inc.	18	$11,223
4	NTLA	Intellia Therapeutics, Inc.	130	$2,199
5	CRSP	CRISPR Therapeutics AG	15	$818

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$11,345	75,981	-24.0%	Shares	Sole	2026-08-04
2026-03-31	$5,080,000	100,000	—	Shares	Sole	2026-04-30
No filing history on record for this holder in this stock.